Yew Bio Pharm Cash Flow - Annual (OTCBB:YEWB)

Add to My Stocks
$0.32 $0 (0%) YEWB stock closing price Feb 20, 2018 (Closing)

The Yew Bio Pharm cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. While its important to look at the Yew Bio Pharm debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Yew Bio Pharm revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. Yew Bio Pharm had cash and cash equivalents of $- at beginning of the year and $- at year end for 2016. Yew Bio Pharm cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Yew Bio Pharm had an outflow of $- from operating activities, $-1.26M spend due to financing activities, and $- outflow due to investing activities for 2016.

View details of Yew Bio Pharm cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow8.93M7.74M----
Net Increase (Decrease) in Assets Liabilities-12.82M-15.43M-1.35M-0.01M-4.59M-0.15M
Cash From (used in) Discontinued Operations------
Other Adjustments Net2.53M1.03M--2.24M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.06M-0.02M--0.29M-0.31M-0.17M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments------
Other Cash Inflow (Outflow) from Investment Activities--2.33M-2.44M-3.39M-0.39M-5.51M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares------
Issuance (Repayment) of Debt Securities------
Increase (Decrease) in Bank & Other Borrowings-1.21M3.21M----
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-0.04M--2.33M--0.06M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.01M-0.03M-0.01M---
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year--1.15M--1.85M
Cash & Equivalents at Year End---1.15M--
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Yew Bio Pharm stock comparison chart provides an easy way to compare the stock price with peers along with details of Yew Bio Pharm stock price history.
The statement of cash flows can be categorized into three main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Yew Bio Pharm is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Yew Bio Pharm stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $- for YEWB.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for YEWB stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $-1.26M for Yew Bio Pharm.

Key Financial Ratios For Yew Bio Pharm Cash Flow

Annual Cash Flow Statements For Yew Bio-Pharm Group, Inc. Peers

China Modern cash flow, Fibria Celulose cash flow, Pope Resources cash flow, Sino Agroo Food cash flow